Tarsus Pharmaceuticals Inc
NASDAQ:TARS
Tarsus Pharmaceuticals Inc
NASDAQ:TARS
Price:
74.77
USD
-0.17%
Market Closed
Market Cap:
$3.2B
Cash Flow Statement
Cash Flow Statement
Tarsus Pharmaceuticals Inc
Tarsus Pharmaceuticals Inc
Currency: USD
| Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||
| Net Income |
(17)
|
(27)
|
(16)
|
(5)
|
(10)
|
(14)
|
(44)
|
(57)
|
(63)
|
(62)
|
(65)
|
(91)
|
(108)
|
(136)
|
(148)
|
(150)
|
(134)
|
(116)
|
(105)
|
(92)
|
(81)
|
(66)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
|
| Stock-Based Compensation |
0
|
1
|
2
|
5
|
7
|
8
|
10
|
11
|
12
|
13
|
15
|
16
|
18
|
20
|
21
|
24
|
26
|
28
|
29
|
30
|
35
|
42
|
|
| Other Non-Cash Items |
4
|
4
|
11
|
15
|
14
|
16
|
12
|
13
|
14
|
14
|
13
|
13
|
15
|
17
|
21
|
25
|
26
|
27
|
27
|
26
|
30
|
38
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
6
|
8
|
9
|
10
|
8
|
8
|
|
| Change in Working Capital |
1
|
1
|
(28)
|
(18)
|
2
|
1
|
32
|
19
|
(1)
|
(1)
|
(4)
|
2
|
3
|
0
|
(7)
|
0
|
7
|
4
|
11
|
(16)
|
(5)
|
15
|
|
| Cash from Operating Activities |
(13)
N/A
|
(21)
-69%
|
(33)
-56%
|
(8)
+76%
|
6
N/A
|
4
-36%
|
0
-93%
|
(25)
N/A
|
(50)
-105%
|
(49)
+2%
|
(56)
-14%
|
(75)
-35%
|
(89)
-18%
|
(117)
-32%
|
(133)
-13%
|
(124)
+7%
|
(100)
+19%
|
(83)
+17%
|
(66)
+21%
|
(81)
-23%
|
(54)
+33%
|
(12)
+77%
|
|
| Investing Cash Flow | |||||||||||||||||||||||
| Capital Expenditures |
(1)
|
(0)
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(6)
|
(6)
|
(5)
|
(6)
|
(1)
|
(7)
|
(7)
|
(7)
|
(9)
|
(10)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(57)
|
(144)
|
(132)
|
(68)
|
41
|
146
|
32
|
(72)
|
(120)
|
(193)
|
(125)
|
(136)
|
(142)
|
(32)
|
|
| Cash from Investing Activities |
(1)
N/A
|
(0)
+15%
|
(1)
-39%
|
(0)
+56%
|
(0)
+7%
|
(1)
-127%
|
(1)
+3%
|
(1)
-19%
|
(58)
-8 384%
|
(145)
-151%
|
(133)
+8%
|
(69)
+48%
|
36
N/A
|
141
+296%
|
27
-81%
|
(78)
N/A
|
(122)
-57%
|
(199)
-64%
|
(132)
+34%
|
(143)
-8%
|
(151)
-6%
|
(42)
+72%
|
|
| Financing Cash Flow | |||||||||||||||||||||||
| Net Issuance of Common Stock |
98
|
40
|
40
|
40
|
(0)
|
0
|
0
|
75
|
75
|
75
|
75
|
1
|
101
|
120
|
229
|
231
|
132
|
115
|
143
|
142
|
144
|
143
|
|
| Net Issuance of Debt |
1
|
0
|
0
|
0
|
0
|
0
|
20
|
20
|
20
|
20
|
5
|
5
|
10
|
10
|
5
|
80
|
75
|
75
|
0
|
0
|
0
|
0
|
|
| Other |
(0)
|
92
|
0
|
0
|
92
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
(35)
|
(35)
|
(35)
|
0
|
(0)
|
0
|
0
|
|
| Cash from Financing Activities |
99
N/A
|
132
+33%
|
132
+0%
|
132
0%
|
92
-30%
|
0
-100%
|
19
+95 550%
|
94
+391%
|
94
0%
|
94
+0%
|
80
-15%
|
6
-93%
|
111
+1 859%
|
130
+18%
|
234
+80%
|
276
+18%
|
171
-38%
|
155
-10%
|
182
+18%
|
142
-22%
|
144
+1%
|
143
0%
|
|
| Change in Cash | |||||||||||||||||||||||
| Net Change in Cash |
86
N/A
|
110
+28%
|
98
-11%
|
124
+26%
|
97
-21%
|
3
-97%
|
19
+492%
|
69
+265%
|
(14)
N/A
|
(100)
-596%
|
(109)
-9%
|
(139)
-27%
|
57
N/A
|
153
+168%
|
128
-17%
|
74
-42%
|
(50)
N/A
|
(128)
-153%
|
(15)
+88%
|
(82)
-433%
|
(61)
+26%
|
89
N/A
|
|
| Free Cash Flow | |||||||||||||||||||||||
| Free Cash Flow |
(13)
N/A
|
(22)
-66%
|
(34)
-55%
|
(8)
+76%
|
6
N/A
|
3
-44%
|
(0)
N/A
|
(25)
-7 788%
|
(51)
-102%
|
(50)
+3%
|
(56)
-14%
|
(77)
-36%
|
(95)
-24%
|
(123)
-30%
|
(139)
-13%
|
(129)
+7%
|
(102)
+21%
|
(90)
+12%
|
(73)
+19%
|
(88)
-21%
|
(63)
+29%
|
(22)
+64%
|
|
Switch to:
Switch to:
See Also
Discover More
